Do Analysts Think Alpine Immune Sciences Inc (ALPN) Is Still Worth Buying In 2024?

Alpine Immune Sciences Inc (NASDAQ:ALPN) does about 2.29M shares in volume on a normal day but saw 2966637 shares change hands in Monday’s trading. The company now has a market cap of 4.26B USD. Its current market price is $64.95, marking an increase of 0.02% compared to the previous close of $64.94. The 52 week high reached by this stock is $64.94 whilst the lowest price level in 52 weeks is $7.71.

Alpine Immune Sciences Inc (ALPN) has a 20-day trading average at $64.63 and the current price is 0.02% off the 52-week high compared with 742.41% distance from its 52-week low. The 50-day simple moving average of the closing price is $50.28 and its 200-day simple moving average is $25.23. If we look at the stock’s price movements over the week, volatility stands at 0.16%, which increases to 0.18% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 83.36 to suggest the stock is overbought.

The consensus objective for the share price is $65.00, suggesting that the stock has a potential upside of 0.08% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 09, 2024 when Guggenheim initiated the stock to “Buy” and issued a price target of $55. Berenberg initiated its price target at $18.

Alpine Immune Sciences Inc (ALPN) stock is up 0.54% over the week and 0.90% over the past month. Its price is 240.77% year-to-date and 734.83% over the past year.

To reach the target analysts have set, the stock logically needs to grow 0.08 percent from here.

The company has a return on investment of -10.79% and return on equity of -14.67%. The beta has a value of 0.85. Price to book ratio is 12.80 and price to sales ratio is 75.34.